Cargando…

Sex differences in residual somatic symptoms in patients with first-episode depression after acute-phase treatment

BACKGROUND: Residual somatic symptoms (RSS) are common in depressed patients, predicting treatment effectiveness. However, sex differences in RSS have received little systematic study. This study was conducted to compare sex differences of RSS in patients with first-episode depression (FED). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Jingjing, Wang, Xiaohong, Zhao, Na, Kang, Chuanyi, Yang, Liying, Zheng, Yue, Liu, Jiacheng, Feng, Lei, Zhu, Xuequan, Ma, Caina, Wu, Wenyuan, Wang, Gang, Hu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9948378/ https://www.ncbi.nlm.nih.gov/pubmed/36814241 http://dx.doi.org/10.1186/s12888-023-04612-3

Ejemplares similares

Comparison of Residual Depressive Symptoms, Functioning, and Quality of Life Between Patients with Recurrent Depression and First Episode Depression After Acute Treatment in China
por: Zu, Si, et al.
Publicado: (2021)

Thyroid dysfunction in young, first-episode and drug-naïve patients with major depressive disorder: prevalence and associated clinical factors
por: Wu, Jinbo, et al.
Publicado: (2023)

The impact of the duration of an untreated episode on improvement of depression and somatic symptoms
por: Hung, Ching-I, et al.
Publicado: (2015)

Somatic symptoms in depression
por: Kapfhammer, Hans-Peter
Publicado: (2006)

Residual symptoms in patients with partial versus complete remission of a major depressive disorder episode: patterns of painful physical symptoms in depression
por: Harada, Eiji, et al.
Publicado: (2016)

Somatic and cognitive-affective depressive symptoms among patients with heart disease: differences by sex and age
por: Dessotte, Carina Aparecida Marosti, et al.
Publicado: (2015)

Group-Based Symptom Trajectory of Intramuscular Administration of Scopolamine Augmentation in Moderate to Severe Major Depressive Disorder: A Post-Hoc Analysis
por: Wang, Xiao, et al.
Publicado: (2023)

Do Somatic Symptoms Predict the Severity of Depression? A Validation Study of the Korean Version of the Depression and Somatic Symptoms Scale
por: Jeon, Sang Won, et al.
Publicado: (2016)

Agomelatine in the treatment of anhedonia, somatic symptoms, and sexual dysfunction in major depressive disorder
por: Huang, Juan, et al.
Publicado: (2023)

Depressive episode as initial symptoms of Perry syndrome
por: Téllez Gómez, A., et al.
Publicado: (2023)

Correlation Analysis Between Attentional Bias and Somatic Symptoms in Depressive Disorders
por: Wang, Yun, et al.
Publicado: (2019)

Are depressive residual symptoms independent of treatments?
por: Figueira, Maria Luisa
Publicado: (2010)

The Impact of Residual Symptoms in Major Depression
por: Israel, Joshua A.
Publicado: (2010)

Study of prodromal and residual symptoms of depression
por: Pede, Vishal B., et al.
Publicado: (2017)

IPS multicentric study: Functional somatic symptoms in depression
por: Grover, Sandeep, et al.
Publicado: (2013)

Depression and Somatic Symptoms in a Non-Western Physician
por: Oh, Philip, et al.
Publicado: (2021)

Somatic symptom severity association with healthcare utilization and costs in surgical inpatients with an episode of abdominal pain
por: Stieler, Melissa, et al.
Publicado: (2022)

Corrigendum: Correlation Analysis Between Attentional Bias and Somatic Symptoms in Depressive Disorders
por: Wang, Yun, et al.
Publicado: (2020)

Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile
por: Penninx, Brenda WJH, et al.
Publicado: (2013)

Female sex and femininity independently associate with common somatic symptom trajectories
por: Ballering, Aranka V., et al.
Publicado: (2022)

Clinical phenotypes of depressed patients with evidence of inflammation and somatic symptoms
por: Foley, Éimear M., et al.
Publicado: (2021)

Health anxiety in patients with depression with somatic symptoms and psychodermatological disorders
por: Ermusheva, A., et al.
Publicado: (2021)

Network analysis of somatic symptoms in Chinese patients with depressive disorder
por: Li, Yang, et al.
Publicado: (2023)

Major depressive episode externalizing symptoms among university students
por: Flesch, Betina Daniele, et al.
Publicado: (2021)

Depressive Symptoms, Alcohol Beliefs and Heavy Episodic Drinking in Adolescents
por: Wellman, Robert J., et al.
Publicado: (2022)

First episode psychosis: the depressive symptoms and suicidal behaviour that follow
por: Mesquita, B. L. B., et al.
Publicado: (2023)

Sex Differences in Factors Affecting Depressive Symptoms in Older People in the Prefrailty Phase
por: Lim, Eun Ju
Publicado: (2020)

Partial remission, residual symptoms, and relapse in depression
por: Paykel, E.S.
Publicado: (2008)

The role of leptin in indirectly mediating “somatic anxiety” symptoms in major depressive disorder
por: Zhu, Yue, et al.
Publicado: (2022)

Scopolamine augmentation of a newly initiated escitalopram treatment for major depressive disorder: study protocol for a randomized controlled trial
por: Zhou, Jingjing, et al.
Publicado: (2019)

The effects of music listening on somatic symptoms and stress markers in the everyday life of women with somatic complaints and depression
por: Feneberg, Anja C., et al.
Publicado: (2021)

Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study
por: Woo, Jong-Min, et al.
Publicado: (2014)

On Somatic Symptoms Measurement: The Scale for Assessment of Somatic Symptoms Revisited
por: Desai, Geetha, et al.
Publicado: (2015)

Predictive potential of somatic symptoms for the identification of subthreshold depression and major depressive disorder in primary care settings
por: Li, Xiuwen, et al.
Publicado: (2023)

Residual symptoms and functioning in depression, does the type of residual symptom matter? A post-hoc analysis
por: Romera, Irene, et al.
Publicado: (2013)

The predictive value of somatic and cognitive depressive symptoms for cytokine changes in patients with major depression
por: Dannehl, Katharina, et al.
Publicado: (2014)

Optimization of measurement-based care (OMBC) for depression based on all-round and continuous assessment: rationale and protocol for a multicenter randomized control clinical trial
por: Zhou, Jingjing, et al.
Publicado: (2022)

Development and Internal Validation of a Novel Model to Identify Inflammatory Biomarkers of a Response to Escitalopram in Patients With Major Depressive Disorder
por: Zhou, Jingjing, et al.
Publicado: (2021)

Characteristics of Residual Symptoms in Korean Patients with Major Depressive Disorder: A Validation Study for the Korean Version of Depression Residual Symptom Scale
por: Park, Sol A, et al.
Publicado: (2018)

The effects of intramuscular administration of scopolamine augmentation in moderate to severe major depressive disorder: a randomized, double-blind, placebo-controlled trial
por: Zhou, Jingjing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tivi9s9999dhpkv2gih34l0gb6